{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T01:53:48Z","timestamp":1770688428193,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Department of Hainan Province","award":["2019RC389"],"award-info":[{"award-number":["2019RC389"]}]},{"name":"Hainan Province Clinical Medical Center","award":["QWYH202175"],"award-info":[{"award-number":["QWYH202175"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>MicroRNA-19b (miR-19b) has been reported to be downregulated in polycystic ovary syndrome (PCOS), while its upstream regulators are unclear. We speculated that miR-19b could potentially form a binding relationship with BBOX1 antisense RNA 1 (BBOX1-AS1), a long non-coding RNA recognized for its critical role in ovarian cancer. Subsequently, we investigated into their interaction in PCOS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression of miR-19b and BBOX1-AS1 in follicular fluid from both control women (n\u2009=\u200980) and women with PCOS (n\u2009=\u200980) was detected by RT-qPCR. Correlations were analyzed with Pearson\u2019 correlation coefficient. The binding of miR-19b to the wild-type (-wt) ad mutant (-mut) BBOX1-AS1 was determined by RNA-RNA pulldown assay. Their interactions were detected by overexpression assay. Bromodeoxyuridine (BrdU) assay was applied for proliferation analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>BBOX1-AS1 was highly upregulated, while miR-19b was downregulated in PCOS. There was no close correlation across PCOS and the control samples. Consistently, they did not regulate the expression of each other in granulosa cells. However, BBOX1-AS1-wt, but not BBOX1-AS1-mut, could directly interact with miR-19b. BBOX1-AS1 suppressed the role of miR-19b in inhibiting granulosa cell proliferation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>BBOX1-AS1 is highly upregulated in PCOS, and it may serve as an endogenous competing RNA for miR-19b to suppress its role in inhibiting granulosa cell proliferation. Our study suggested the role of BBOX1-AS1 as a potential target to treat PCOS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02632-5","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T11:01:59Z","timestamp":1695294119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The long non-coding RNA BBOX1 antisense RNA 1 is upregulated in polycystic ovary syndrome (PCOS) and suppresses the role of microRNA-19b in the proliferation of ovarian granulose cells"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohui","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bangbei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yejuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"2632_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cnur.2018.04.008","volume":"53","author":"RK Meier","year":"2018","unstructured":"Meier RK. Polycystic ovary syndrome. Nurs Clin North Am. 2018;53:407\u201320.","journal-title":"Nurs Clin North Am"},{"key":"2632_CR2","doi-asserted-by":"publisher","first-page":"100494","DOI":"10.1016\/j.lanwpc.2022.100494","volume":"25","author":"R Yang","year":"2022","unstructured":"Yang R, et al. Changes in the prevalence of polycystic ovary syndrome in China over the past decade. Lancet Reg Health West Pac. 2022;25:100494.","journal-title":"Lancet Reg Health West Pac"},{"key":"2632_CR3","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","volume":"25","author":"S Risal","year":"2019","unstructured":"Risal S, Pei Y, Lu H, Manti M, Fornes R, Pui HP, Zhao Z, Massart J, Ohlsson C, Lindgren E, et al. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat Med. 2019;25:1894\u2013904.","journal-title":"Nat Med"},{"key":"2632_CR4","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","volume":"105","author":"H Cena","year":"2020","unstructured":"Cena H, Chiovato L, Nappi RE, Obesity. Polycystic ovary syndrome, and infertility: a New Avenue for GLP-1 receptor agonists. J Clin Endocrinol Metab. 2020;105:e2695\u20132709.","journal-title":"J Clin Endocrinol Metab"},{"key":"2632_CR5","first-page":"142","volume":"8","author":"R Dumitrescu","year":"2015","unstructured":"Dumitrescu R, Mehedintu C, Briceag I, Purcarea VL, Hudita D. The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms. J Med Life. 2015;8:142\u20135.","journal-title":"J Med Life"},{"key":"2632_CR6","doi-asserted-by":"crossref","first-page":"117955811987404","DOI":"10.1177\/1179558119874042","volume":"12","author":"TM Barber","year":"2019","unstructured":"Barber TM, Hanson P, Weickert MO, Franks S. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;12:1179558119874042.","journal-title":"Clin Med Insights Reprod Health"},{"key":"2632_CR7","first-page":"104","volume":"6","author":"EK Barthelmess","year":"2014","unstructured":"Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed). 2014;6:104\u201319.","journal-title":"Front Biosci (Elite Ed)"},{"key":"2632_CR8","doi-asserted-by":"crossref","unstructured":"Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R. Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: pregnancy-related and long-term Health Consequences. J Clin Endocrinol Metab. 2021.","DOI":"10.1210\/clinem\/dgab613"},{"key":"2632_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.15296\/ijwhr.2019.15","volume":"7","author":"F Khodaeifar","year":"2019","unstructured":"Khodaeifar F, Fazljou SB, Khaki A, Torbati M, Madarek EOS, Khaki AA, Shokoohi M, Dalili AH. Investigating the role of hydroalcoholic extract of Apium graveolens and cinnamon zeylanicum on metabolically change and ovarian oxidative injury in a rat model of polycystic ovary syndrome. Int J Women\u2019s Health Reprod Sci. 2019;7:92\u20138.","journal-title":"Int J Women\u2019s Health Reprod Sci"},{"key":"2632_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/clinem\/dgab613","volume":"107","author":"C Riestenberg","year":"2022","unstructured":"Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R. Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: pregnancy-related and long-term Health Consequences. J Clin Endocrinol Metabolism. 2022;107:575\u201385.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2632_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.tem.2018.08.005","volume":"29","author":"KA Walters","year":"2018","unstructured":"Walters KA, Gilchrist RB, Ledger WL, Teede HJ, Handelsman DJ, Campbell RE. New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins. Trends Endocrinol Metab. 2018;29:841\u201352.","journal-title":"Trends Endocrinol Metab"},{"key":"2632_CR12","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1210\/jc.2016-1202","volume":"101","author":"JT George","year":"2016","unstructured":"George JT, Kakkar R, Marshall J, Scott ML, Finkelman RD, Ho TW, Veldhuis J, Skorupskaite K, Anderson RA, McIntosh S, et al. Neurokinin B receptor antagonism in women with polycystic ovary syndrome: a Randomized, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2016;101:4313\u201321.","journal-title":"J Clin Endocrinol Metab"},{"key":"2632_CR13","doi-asserted-by":"publisher","first-page":"118174","DOI":"10.1016\/j.lfs.2020.118174","volume":"259","author":"M Abdalla","year":"2020","unstructured":"Abdalla M, Deshmukh H, Atkin SL, Sathyapalan T. miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): a review. Life Sci. 2020;259:118174.","journal-title":"Life Sci"},{"key":"2632_CR14","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","volume":"21","author":"M Huarte","year":"2015","unstructured":"Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253\u201361.","journal-title":"Nat Med"},{"key":"2632_CR15","first-page":"1354","volume":"9","author":"MC Jiang","year":"2019","unstructured":"Jiang MC, Ni JJ, Cui WY, Wang BY, Zhuo W. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am J Cancer Res. 2019;9:1354\u201366.","journal-title":"Am J Cancer Res"},{"key":"2632_CR16","doi-asserted-by":"publisher","first-page":"12289","DOI":"10.1080\/21655979.2022.2070965","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Zhu L, Luo Y. Long non-coding RNA HLA-F antisense RNA 1 inhibits the maturation of microRNA-613 in polycystic ovary syndrome to promote ovarian granulosa cell proliferation and inhibit cell apoptosis. Bioengineered. 2022;13:12289\u201397.","journal-title":"Bioengineered"},{"key":"2632_CR17","first-page":"4889","volume":"17","author":"Z Zhong","year":"2018","unstructured":"Zhong Z, Li F, Li Y, Qin S, Wen C, Fu Y, Xiao Q. Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome. Mol Med Rep. 2018;17:4889\u201398.","journal-title":"Mol Med Rep"},{"key":"2632_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s43032-020-00366-5","volume":"28","author":"H Yao","year":"2021","unstructured":"Yao H, Chen R, Yang Y, Jiang J. LncRNA BBOX1-AS1 aggravates the development of ovarian Cancer by sequestering mir-361-3p to Augment PODXL expression. Reprod Sci. 2021;28:736\u201344.","journal-title":"Reprod Sci"},{"issue":"4","key":"2632_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/humrep\/det469","volume":"29","author":"MP Lauritsen","year":"2014","unstructured":"Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Andersen AN. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-M\u00fcllerian hormone. Hum Reprod. 2014;29(4):791\u2013801.","journal-title":"Hum Reprod"},{"key":"2632_CR20","doi-asserted-by":"publisher","first-page":"e4331","DOI":"10.21769\/BioProtoc.4331","volume":"12","author":"JK Uppala","year":"2022","unstructured":"Uppala JK, Ghosh C, Sabat G, Dey M. Pull-down of biotinylated RNA and Associated Proteins. Bio-protocol. 2022;12:e4331\u20131.","journal-title":"Bio-protocol"},{"key":"2632_CR21","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.theriogenology.2005.04.016","volume":"64","author":"M Moussa","year":"2005","unstructured":"Moussa M, Perreau C, Baril G, Duchamp G, Vidament M, Daels P, Bruyas JF, Mermillod P. Comparison of cell proliferation index in equine and caprine embryos using a modified BrdU incorporation assay. Theriogenology. 2005;64:1823\u201332.","journal-title":"Theriogenology"},{"key":"2632_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00404-016-4068-z","volume":"294","author":"S Mikaeili","year":"2016","unstructured":"Mikaeili S, Rashidi BH, Safa M, Najafi A, Sobhani A, Asadi E, Abbasi M. Altered FoxO3 expression and apoptosis in granulosa cells of women with polycystic ovary syndrome. Arch Gynecol Obstet. 2016;294:185\u201392.","journal-title":"Arch Gynecol Obstet"},{"key":"2632_CR23","first-page":"210","volume":"21","author":"A Majdi Seghinsara","year":"2019","unstructured":"Majdi Seghinsara A, Shoorei H, Hassanzadeh Taheri MM, Khaki A, Shokoohi M, Tahmasebi M, Khaki AA, Eyni H, Ghorbani S, Riahi Rad KH, et al. Panax ginseng Extract improves Follicular Development after Mouse Preantral follicle 3D culture. Cell J. 2019;21:210\u20139.","journal-title":"Cell J"},{"key":"2632_CR24","doi-asserted-by":"crossref","unstructured":"Delkhosh A, Delashoub M, Tehrani AA, Bahrami AM, Niazi V, Shoorei H, Banimohammad M, Kalarestaghi H, Shokoohi M, Agabalazadeh A et al. Upregulation of FSHR and PCNA by administration of coenzyme Q10 on cyclophosphamide-induced premature ovarian failure in a mouse model. 2019; 33:e22398.","DOI":"10.1002\/jbt.22398"},{"key":"2632_CR25","doi-asserted-by":"crossref","unstructured":"Shokoohi M, Soltani M, Abtahi-Eivary S-H, Niazi V, Poor M, Ravaei H, Salimnejad R, Moghimian M, Shoorei H. Effect of hydroalcoholic extract of Olea europaea on apoptosis related genes and oxidative stress in a rat model of torsion\/detorsion induced ovarian damage. 2019; 8:148\u201356.","DOI":"10.4103\/2305-0500.262831"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02632-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02632-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02632-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T09:06:04Z","timestamp":1700384764000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02632-5"}},"subtitle":["Short title: BBOX1 antisense RNA 1 in cell proliferation"],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2632"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02632-5","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"31 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study passed the review of the Ethics Committee of Hainan Women and Children\u2019s Medical Center and was carried out following the World Medical Association Declaration of Helsinki. All participants received written informed consent and provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"508"}}